Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A card game could open the door to better End-of-Life conversations

NCT ID NCT06384417

Symptom relief Sponsor: Milton S. Hershey Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study tests whether a conversation game called 'Hello' can help people with cancer and their loved ones discuss advance care planning—decisions about future medical care. Participants will play either the Hello game or a similar conversation game, complete questionnaires, and join focus groups. The goal is to see if the game is acceptable and useful, and whether it affects healthcare use like hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hello for Cancer game
What this could lead to
If effective, this game could become a simple tool to help cancer patients and families have important conversations about care preferences, potentially improving quality of life and reducing unwanted hospitalizations.
What could go wrong
This is a small, early-stage study focused on feasibility and adaptation, so results may not be generalizable. The game may not change actual healthcare decisions or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Patient with Cancer: * Adults (\> 18 years old) * Able to speak and read English and/or Spanish * Be an individual diagnosed with a solid tumor cancer (e.g., breast, colon, lung, melanoma, head and neck, or genitourinary/prostate cancer) as verified by primary oncologist or is the chosen caregiver for a participant with those cancers * Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health Exclusion Criteria Patient with Cancer: * Has completed an advance directive since cancer diagnosis as verified by presence in the patient's medical chart * Has not received treatment for their cancer at a Penn State Health facility in the past year * Unable to consent to participate in study Inclusion Criteria Caregiver/Loved one: * Adults (\> 18 years old) * Able to speak and read English and/or Spanish * Be the chosen caregiver for a participant with cancer Exclusion Criteria Caregiver/Loved one: \* Unable to consent to participate in study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm cancer colorectal cancer colorectal neoplasm gastric cancer gastric neoplasm head and neck cancer Head and Neck Neoplasms liver cancer Liver Neoplasms lung cancer lung neoplasm malignant pancreatic neoplasm melanoma neoplasm pancreatic neoplasm Urogenital Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Colorectal cancer Gastric cancer Genito-urinary cancer Head and neck cancer Liver cancer Lung cancer Melanoma Pancreatic cancer

Contacts and locations

Locations

  • Penn State Cancer Institute

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.